Timothy Archer, serving as both President and Chief Executive Officer of Lam Research Corp (NASDAQ:LRCX), has formally reported the execution of a stock sale totaling approximately $11.7 million. This disclosure follows a recent filing submitted to the Securities and Exchange Commission, detailing the specific parameters of the transaction. The executive disposed of 30,000 shares of common stock, which were sold at a precise price point of $390.01 per share. The transaction was finalized on July 2, 2026, marking a significant movement in the company's equity.
Key details surrounding the transaction indicate that the sale was executed under the framework of a Rule 10b5-1 trading plan. This pre-arranged trading mechanism was originally adopted by Mr. Archer on February 24, 2026. The utilization of such a plan typically allows executives to trade company stock at predetermined times, regardless of subsequent market fluctuations or internal information developments.
At the time of the reported sale, Lam Research shares were trading at $355.81. This current price point stands in contrast to the stock's historical performance, which has delivered a remarkable 258% return over the past year. Despite this substantial appreciation, analysis from InvestingPro suggests that the stock may currently be trading at overvalued levels. Specifically, the company is currently operating at a price-to-earnings (P/E) ratio of 67.5, a metric that has drawn attention from valuation-focused observers.
While the sale represents a divestment, Mr. Archer simultaneously engaged in an acquisition activity related to the company's equity. He acquired an equivalent number of 30,000 shares of Lam Research common stock through the exercise of employee stock options. These shares were acquired at an exercise price of $30.033 per share, resulting in a total transaction value of $900,990. The options that were exercised were part of a specific grant that became exercisable in three equal installments on March 2, 2021, March 2, 2022, and March 2, 2023. These options are set to expire on March 2, 2027.
Following the completion of these transactions, Mr. Archer's direct holdings in Lam Research common stock stand at 1,075,966 shares. This figure includes shares that are subject to unvested restricted stock units. Furthermore, the executive maintains indirect holdings through retirement vehicles. He holds 48,025.745 shares indirectly through a 401(k) plan and an additional 5,670.026 shares indirectly through a spouse's 401(k) plan. This comprehensive holding structure underscores the executive's significant financial interest in the company's long-term performance.
In the broader market context, Lam Research has recently been the subject of multiple adjustments to stock price targets by various financial firms. Lynx Equity raised its price target for Lam Research to $400. This adjustment was driven by increased estimates for wafer fabrication equipment (WFE) extending through 2028. The firm projects that Lam Research's revenue will reach $48.2 billion by 2028, with earnings per share estimated at $13.6.
Mizuho also increased its price target for Lam Research to $380. The firm cited a positive outlook for wafer fabrication equipment, which is being driven by expansion in AI logic and memory capacity. This perspective aligns with broader industry trends where artificial intelligence infrastructure demands are influencing equipment manufacturing forecasts.
Cantor Fitzgerald has also adjusted its outlook, raising its price target to $500. The firm highlighted Lam Research's gains in market share among semiconductor capital equipment manufacturers. Prior to this adjustment, Cantor Fitzgerald had raised its target to $425, emphasizing AI-driven advanced packaging as a key growth driver. In related developments, Cantor Fitzgerald also raised its price target for KLA Corporation to $325, maintaining an Overweight rating due to a positive equipment outlook. These adjustments reflect growing confidence in the semiconductor equipment sector, with Lam Research and KLA Corporation receiving notable attention from analysts.
Investors seeking deeper insights into LRCX's valuation and additional ProTips can access a comprehensive Pro Research Report available on InvestingPro. The stock data indicates a real-time price of $355.08, reflecting a change of +3.67 (+1.04%).